-
1.
公开(公告)号:EP3498281B1
公开(公告)日:2024-08-28
申请号:EP17839530.7
申请日:2017-08-09
IPC分类号: A61K31/5383 , A61P43/00 , A61P31/16 , A61P31/12 , C07D498/14 , A61K9/00 , A61K9/70 , A61K9/20 , A61K9/48 , A61K9/16 , A61K9/06
CPC分类号: A61K31/5383 , A61P31/16 , A61P31/12 , A61P43/00 , C07D498/14 , A61K9/2018 , A61K9/4858 , A61K9/1623 , A61K9/0056 , A61K9/0095 , A61K9/0019 , A61K9/06 , A61K9/0014 , A61K9/0075 , A61K9/7038
-
公开(公告)号:EP4410292A1
公开(公告)日:2024-08-07
申请号:EP22876159.9
申请日:2022-09-27
发明人: TACHIBANA Yuki , UEHARA Shota , UNOH Yuto , NAKAHARA Kenji , TAODA Yoshiyuki , KASAMATSU Koji , YAMATSU Yukiko , ANDO Shigeru , FUKAO Keita , NOBORI Haruaki , KURODA Takayuki , TOBA Shinsuke , UEMURA Kentaro , MARUYAMA Yuki , SASAKI Michihito , SAWA Hirofumi
IPC分类号: A61K31/5355 , A61K31/53 , A61K31/5377 , A61P31/12 , A61P31/14 , A61P43/00
CPC分类号: A61P31/12 , A61P43/00 , A61K31/5355 , A61K31/5377 , A61K31/53 , A61P31/14
摘要: The present invention provides a pharmaceutical composition comprising a compound exhibiting coronavirus proliferation inhibitory activity.
A pharmaceutical composition comprising a compound represented by the formula: wherein Y is N; R1 is substituted or unsubstituted aromatic heterocyclyl; R2 is substituted or unsubstituted 6-membered aromatic carbocyclyl; R3 is substituted or unsubstituted aromatic heterocyclyl; -X- is -NH-; m is 0 or 1; R5a is a hydrogen atom; R5b is a hydrogen atom; n is 1; R4a is a hydrogen atom; and R4b is a hydrogen atom, or a pharmaceutically acceptable salt thereof.-
公开(公告)号:EP3391888B1
公开(公告)日:2023-09-27
申请号:EP16875668.2
申请日:2016-12-14
IPC分类号: A61K31/53 , A61K31/5383 , A61K31/542 , A61K31/661 , A61K31/6615 , A61K39/395 , A61K45/00 , A61P31/16 , A61P43/00
-
公开(公告)号:EP3045206B2
公开(公告)日:2023-02-15
申请号:EP16154531.4
申请日:2006-04-28
IPC分类号: A61P31/18 , A61K31/4985 , C07D498/04
-
公开(公告)号:EP3287443B1
公开(公告)日:2021-10-27
申请号:EP16783270.8
申请日:2016-04-22
发明人: TANAKA, Satoru , OGAWA, Tomoyuki , KAI, Hiroyuki , OGATA, Yuki , HIRAI, Keiichiro , KUROSE, Noriyuki , FUJII, Yasuhiko
IPC分类号: C07D213/69 , A61K31/4412 , A61K31/505 , A61K31/506 , A61K31/53 , A61K31/5377 , A61P1/02 , A61P1/04 , A61P1/16 , A61P1/18 , A61P3/10 , A61P9/10 , A61P11/00 , A61P11/06 , A61P11/08 , A61P13/00 , A61P13/08 , A61P13/10 , A61P13/12 , A61P17/02
-
公开(公告)号:EP3330256B1
公开(公告)日:2021-06-16
申请号:EP16821422.9
申请日:2016-07-06
发明人: YUKIMASA, Akira , NAKAMURA, Kenichiroh , INAGAKI, Masanao , KANO, Kazuya , FUJIU, Motohiro , YAMAGUCHI, Hiroki , HATA, Kayoko , INOUE, Takatsugu
IPC分类号: C07D231/38 , A61K31/4155 , A61K31/422 , A61K31/433 , A61K31/437 , A61K31/4439 , A61K31/454 , A61K31/506 , A61K31/519 , A61P1/18 , A61P13/08 , A61P13/10 , A61P17/00 , A61P19/02 , A61P25/02 , A61P25/04 , A61P29/00 , A61P35/00 , A61P37/08 , C07D405/12
-
公开(公告)号:EP3315128B1
公开(公告)日:2021-05-19
申请号:EP15896367.8
申请日:2015-06-26
IPC分类号: A61K31/427 , A61P25/00
-
公开(公告)号:EP3428170B1
公开(公告)日:2021-01-06
申请号:EP18189193.8
申请日:2016-04-27
IPC分类号: C07D498/14 , A61P31/16 , A61K31/5383
-
公开(公告)号:EP3415491B1
公开(公告)日:2020-11-18
申请号:EP17766668.2
申请日:2017-03-14
申请人: Shionogi & Co., Ltd
发明人: TOYAMA, Takayuki , MIYAKE, Naoki
IPC分类号: C07C41/26 , C07C43/23 , A61K31/085
-
公开(公告)号:EP3670496A2
公开(公告)日:2020-06-24
申请号:EP20151537.6
申请日:2014-10-17
申请人: Shionogi & Co., Ltd.
发明人: KOBAYASHI, Naotake , ASAHI, Kentarou , TOMIDA, Yutaka , OHDAN, Masahide , FUMOTO, Masataka , SASAKI, Yoshikazu , KURAHASHI, Kana , INOUE, Takatsugu , URABE, Tomomi , NISHIURA, Yuji , IWATSU, Masafumi , MIYAZAKI, Keisuke , OHYABU, Naoki , WADA, Toshihiro , KATOU, Manabu
IPC分类号: C07C233/18 , A61K31/165 , A61K31/17 , A61K31/416 , A61K31/423 , A61K31/426 , A61K31/4725 , A61K31/4965 , A61K31/497 , A61K31/506 , A61K31/517 , A61K31/553 , A61P3/04 , A61P3/10 , A61P43/00 , C07C233/31 , C07C275/24 , C07D213/64 , C07D213/69 , C07D231/56
摘要: The object of the present invention is to provide novel compounds having ACC2 inhibiting activity. In addition, the object of the present invention is to provide a pharmaceutical composition comprising the compound.
A compound of formula (I):
wherein
R 1 is substituted or unsubstituted fused aromatic heterocyclyl etc.,
ring A is substituted or unsubstituted non-aromatic carbocycle etc.,
-L 1 - is -O-(CR 6 R 7 )m- etc.,
-L 2 - is -O-(CR 6 R 7 )n- etc.,
each R 6 and R 7 are independently hydrogen, halogen etc.,
R 2 is substituted or unsubstituted alkyl,
R 3 is hydrogen or substituted or unsubstituted alkyl,
R 4 is substituted or unsubstituted alkylcarbonyl etc..
-
-
-
-
-
-
-
-
-